|
Market Closed -
Hong Kong S.E.
04:08:04 2026-09-14 am EDT
|
5-day change | 1st Jan Change | ||
| 8.865 HKD | +1.78% |
|
-8.42% | +5.16% |
| Sep. 09 | CSPC Pharma's SYH9087 Injection Gets China Nod for Parkinson's Disease Trial | MT |
| Sep. 09 | CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug | MT |
| Market Cap | 101B 12.92B 11.19B 10.56B 9.57B 17.96B 1,235B 18.11B 126B 48.52B 628B 48.53B 47.47B 1,994B | P/E 2026 * |
9.89x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 90.14B 11.49B 9.95B 9.39B 8.51B 15.97B 1,098B 16.1B 112B 43.15B 559B 43.16B 42.21B 1,774B | EV / Sales 2026 * |
2.34x | EV / Sales 2027 * | 2.44x |
| Free-Float |
67.42% | Yield 2026 * |
5.02% | Yield 2027 * | 4.11% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1093 | Delayed | |
OTC Markets
| CHJTF | Delayed | |
|
Börse Stuttgart
| CVG | Delayed | |
|
Boerse Muenchen
| CVG | Real-time | |
|
Deutsche Boerse AG
| CVG | Delayed | |
|
Tradegate
| CVG | Real-time |
| 1 day | +1.78% | ||
| 1 week | -8.47% | ||
| Current month | -4.06% | ||
| 1 month | +0.17% | ||
| 3 months | +22.44% | ||
| 6 months | +3.20% | ||
| Current year | +5.16% |
| 1 week | 8.52 |  | 9.64 |
| 1 month | 8.52 | | 10.17 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 10.96 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 2012-01-19 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/26 | Other | Director | -700,000 | 0.0061% | ||
| 5/29/26 | Other | Chairman | 9,402,000 | 0.0816% | ||
| 5/28/26 | Other | Chairman | 40,000,000 | 0.3471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.78% | -8.47% | -14.35% | +54.71% | 12.7B | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +1.58% | -6.19% | +20.71% | +44.22% | 351.75B | |
| Weighted average by Cap. | +1.04% | -4.44% | +33.29% | +57.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.53B 4.91B 4.25B 4.01B 3.64B 6.83B 469B 6.88B 47.88B 18.44B 239B 18.45B 18.04B 758B | 35.63B 4.54B 3.93B 3.71B 3.37B 6.31B 434B 6.37B 44.28B 17.06B 221B 17.06B 16.69B 701B |
| Net income | 10.23B 1.3B 1.13B 1.07B 966M 1.81B 125B 1.83B 12.71B 4.9B 63.4B 4.9B 4.79B 201B | 6.97B 889M 770M 727M 659M 1.24B 84.97B 1.25B 8.67B 3.34B 43.25B 3.34B 3.27B 137B |
| Net Debt | -11.21B -1.43B -1.24B -1.17B -1.06B -1.99B -137B -2B -13.94B -5.37B -69.54B -5.37B -5.25B -221B | -14.28B -1.82B -1.58B -1.49B -1.35B -2.53B -174B -2.55B -17.75B -6.84B -88.55B -6.84B -6.69B -281B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | HK$8.865 | +1.78% | 95,912,466 |
| 26-09-11 | HK$8.710 | -0.68% | 111,543,206 |
| 26-09-10 | HK$8.770 | -3.63% | 150,348,516 |
| 26-09-09 | HK$9.100 | -3.40% | 203,238,486 |
| 26-09-08 | HK$9.420 | -2.69% | 71,809,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
